Melvin H. Van Woert - Concepedia

Author

Melvin H. Van Woert

Also Known As

M H Van Woert, M H van Woert, M. H. VAN WOERT, M. H. Van Woert, M. H. van Woert, M.H. Van Woert, M.H.Van Woert, MELVIN H. VAN WOERT, Melvin H. Van Woert, Melvin H. Woert

Publications

4.1K

Citations

H-Index

118

Concepts

All Affiliations

Yale University Icahn School of Medicine at Mount Sinai Brookhaven National Laboratory

About

Melvin H. Van Woert is an author at Yale University specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	52	3.7K
2	Social Sciences	14	17	1K
3	Health Sciences	7	7	337
4	Natural Sciences	3	3	61
5	Public Health	2	2	34

Melvin H. Van Woert

Publications

Citations

H-Index

Page 1

	Year	Citations
Aromatic Amino Acids and Modification of Parkinsonism George C. Cotzias, Melvin H. Van Woert, Lewis M. Schiffer New England Journal of Medicine NeuropeptidesBiochemistrySubstantia NigraMedicineParkinson Disease	1967	1.5K
Brain Peroxidase and Catalase in Parkinson Disease L. M. Ambani, Melvin H. Van Woert, Samantha Murphy Archives of Neurology Lipid PeroxidationRedox BiologySocial SciencesOxidative StressNormal Brain	1975	402
Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa Melvin H. Van Woert, David Rosenbaum, John Howieson, New England Journal of Medicine Neurological DisorderBrain SerotoninPsychotropic MedicationPsychopharmacologyPharmacotherapy	1977	127
Regulation of striatal acetylcholine concentration by dopamine receptors Vimala H. Sethy, Melvin H. Van Woert Nature NeurotransmitterNeuropharmacologyDopamine ReceptorsNeuroscienceNeurology	1974	113
Therapy of intention myoclonus with L‐5‐hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486 Melvin H. Van Woert, Vimala H. Sethy Neurology Peripheral Decarboxylase InhibitorPostanoxic Intention MyoclonusBrain SerotoninPsychotropic MedicationPharmacotherapy	1975	102
Start Hesitation — A Side Effect of Long-Term Levodopa Therapy L. M. Ambani, Melvin H. Van Woert New England Journal of Medicine Long-term Levodopa SyndromeParkinson DiseaseRebound EffectPharmacologyLevodopa Therapy	1973	93
SPECTROSCOPIC STUDIES OF <i>SUBSTANTIA NIGRA</i> PIGMENT IN HUMAN SUBJECTS* Melvin H. Van Woert, Kedar N. Prasad, Donald C. Borg Journal of Neurochemistry SpectroscopySpectrochemical AnalysisSpectroscopic MethodOphthalmology	1967	93
Choline and acetylcholine: Regional distribution and effect of degeneration of cholinergic nerve terminals in the rat hippocampus Vimala H. Sethy, R.H. Roth, M. J. Kuhar, Neuropharmacology Rat HippocampusNeurophysiologyNeuroanatomyPhysiologyRegional Distribution	1973	69
Cholinergic neurons: effect of acute septal lesion on acetylcholine and choline content of rat hippocampus Vimala H. Sethy, Michael J. Kuhar, Robert H. Roth, Brain Research Choline ContentRat HippocampusNeurophysiologyNeuroanatomySynaptic Transmission	1973	67
Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa Melvin H. Van Woert, Peter S. Mueller Clinical Pharmacology & Therapeutics NutritionMetabolic DisorderInsulin SignalingMetabolic SyndromeLevodopa Therapy	1971	65

Page 1